The exclusive license and supply agreement will allow UPL to commercialise a new biocontrol technology from Agrauxine in the United States
UPL, a global leader in sustainable agriculture solutions, has recently announced a strategic collaboration with Agrauxine by Lesaffre, a subsidiary of Lesaffre company specializing in biological crop solutions. The exclusive license and supply agreement will allow UPL to commercialise a new biocontrol technology from Agrauxine in the United States.
The collaboration with Agrauxine broadens the biological offerings that NPP will deliver in the United States. A new biocontrol technology from the collaboration is awaiting US EPA registration, expected later in 2022.
Agrauxine by Lesaffre is a business unit of Lesaffre, a key global player in fermentation for more than a century. Based in France, Agrauxine develops, manufactures and commercialises biosolutions from selected natural strains of fungi, bacteria and yeast microorganisms.
“Agrauxine is a recognised global innovator in the development of sustainable solutions derived from microorganisms that address critical challenges of growers,” says Jim Petta, Natural Plant Protection Head, North America. “This partnership is a natural for us, and it’s a collaboration that will strengthen our BioSolutions product pipeline to deliver enhanced value for US growers.”
Says Hugo Bony, CEO, Agrauxine by Lesaffre, “We have strong ambitions for growth in the U.S. market. We’re looking forward to our partnership with UPL to deliver this new biocontrol technology derived from microorganisms that will help growers overcome crop stresses during germination, emergence and early plant growth.”
